ArticleThe Pan African medical journal2025
Can implementation research be a game changer for measles elimination in Africa?
Article in The Pan African medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Many countries in Africa still experience large and disruptive measles outbreaks despite the availability of a highly effective vaccine. In 2023, the estimated number of measles cases and deaths in the World Health Organization African Region was 4,801,946 cases and 75,942 deaths, respectively. Studies have shown that multiple implementation challenges affect equitable access and uptake of measles-containing vaccines, with specific barriers varying by settings. Implementation research, which emerged in response to know-do gaps in health systems, has several tools that can be used to gain a thorough understanding of the barriers to measles vaccination and how to address them using appropriate implementation strategies. In this commentary, we discuss why investment in implementation research for measles elimination is a programmatic imperative for countries in the WHO African Region.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.